187 related articles for article (PubMed ID: 11367872)
1. Bioequivalence of two lamivudine tablet formulations.
Santos-Magalhães NS; Pontes A; Cavalcante RM; Costa RM; Rangel FA; Guimarães MI; de Carvalho JN; de Souza SD; de Oliveira HM; Esteves IL; Ramalho MS; Vieira SL; Alves AJ
Arzneimittelforschung; 2001; 51(4):310-4. PubMed ID: 11367872
[TBL] [Abstract][Full Text] [Related]
2. A single-dose, randomized, open-label, two-period crossover bioequivalence study comparing a fixed-dose pediatric combination of lamivudine and stavudine tablet for oral suspension with individual liquid formulations in healthy adult male volunteers.
Monif T; Reyar S; Tiwari HK; Tippabhotla SK; Khuroo A; Thudi NR; Ahmed S; Raghuvanshi R
Arzneimittelforschung; 2009; 59(2):104-8. PubMed ID: 19338141
[TBL] [Abstract][Full Text] [Related]
3. Bioequivalence study of generic tablet formulations containing ethinylestradiol and chlormadinone acetate in healthy female volunteers.
Bonn M; Eydeler U; Barkworth M; Rovati LC
Arzneimittelforschung; 2009; 59(12):651-8. PubMed ID: 20108652
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
5. Single dose bioequivalence study of alpha-methyldopa tablet formulations using a modified HPLC method.
Valizadeh H; Nemati M; Hallaj-Nezhadi S; Ansarin M; Zakeri-Milani P
Arzneimittelforschung; 2010; 60(10):607-11. PubMed ID: 21125810
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers.
Bawazir SA; Gouda MW; El-Sayed YM; Al-Khamis KI; Al-Yamani MJ; Niazy EM; Al-Rashood KA
Int J Clin Pharmacol Ther; 1998 May; 36(5):270-4. PubMed ID: 9629991
[TBL] [Abstract][Full Text] [Related]
7. Comparative bioavailability of two tablet formulations of acyclovir in healthy volunteers.
Al-Yamani MJ; Al-Khamis KI; El-Sayed YM; Bawazir SA; Al-Rashood KA; Gouda MW
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):222-6. PubMed ID: 9587049
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the bioequivalence of zidovudine 100 mg capsules in healthy Thai male volunteers.
Chompootaweep S; Poonsrisawat J; Xumseang P
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S79-85. PubMed ID: 17722305
[TBL] [Abstract][Full Text] [Related]
9. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
Bittner B; Riek M; Holmes B; Grange S
Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence study of finasteride. Determination in human plasma by high-pressure liquid chromatography coupled to tandem mass spectrometry.
de Menezes FG; Ribeiro W; Ifa DR; de Moraes ME; de Moraes MO; De Nucci G
Arzneimittelforschung; 2001 Feb; 51(2):145-50. PubMed ID: 11258044
[TBL] [Abstract][Full Text] [Related]
11. Comparative bioavailability of two tablet formulations of metoclopramide hydrochloride.
el-Sayed YM; Niazy EM; al-Rayes S; Ismail AO; Gouda MW
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):136-9. PubMed ID: 7599911
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability of two dexamethasone tablet formulations in Indonesian healthy volunteers.
Harahap Y; Sasongko L; Prasaja B; Indriati E; Lusthom W; Lipin
Arzneimittelforschung; 2009; 59(4):191-4. PubMed ID: 19517895
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence study of two perindopril erbumine tablet formulations in healthy volunteers.
Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Santoso ID; Arland JA; Setiawati A; Lian LY
Arzneimittelforschung; 2011; 61(4):234-8. PubMed ID: 21650082
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioequivalence study of escitalopram oxalate formulations after single-dose administration in healthy Chinese male volunteers.
Li J; Tian Y; Zhang ZJ; Wang N; Ren X; Chen Y
Arzneimittelforschung; 2009; 59(5):228-32. PubMed ID: 19537522
[TBL] [Abstract][Full Text] [Related]
16. Determination of lamivudine in human plasma by HPLC and its use in bioequivalence studies.
Kano EK; dos Reis Serra CH; Koono EE; Andrade SS; Porta V
Int J Pharm; 2005 Jun; 297(1-2):73-9. PubMed ID: 15907596
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence evaluation of a fixed dose combination lamivudine + stavudine tablet with concurrent administration of lamivudine tablet and stavudine capsule in healthy volunteers.
Chachad S; Lulla A; Malhotra G; Purandare S
Arzneimittelforschung; 2009; 59(10):537-40. PubMed ID: 19998583
[TBL] [Abstract][Full Text] [Related]
18. Comparative bioavailability of two tablet formulations of ibuprofen.
el-Sayed YM; Gouda MW; al-Khamis KI; al-Meshal MA; al-Dhawailie AA; al-Rayes S; Bin-Salih SA; al-Rashood KA
Int J Clin Pharmacol Ther; 1995 May; 33(5):294-8. PubMed ID: 7655769
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence study of atorvastatin tablets.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):573-7. PubMed ID: 15497662
[TBL] [Abstract][Full Text] [Related]
20. In vivo bioequivalence of oral antidiabetic agents: pioglitazone tablets.
Wong H; Ozalp Y; Lainesse A; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):618-24. PubMed ID: 15497670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
